Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Numinus Wellness Inc (LKYSD)

Numinus Wellness Inc (LKYSD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance

Most Recent Stories

More News
Psychedelic Drugs Market Projected to Reach $6.85 Billion by 2027

, /PRNewswire/ -- The psychedelic drugs market is projected to grow at a CAGR of 16.3% over the next eight years to , according to Data Bridge Market Research. The key factors that will fuel this growth...

AGN : 193.02 (+0.02%)
JNJ : 145.21 (+1.99%)
NUMI.VN : 0.300 (-6.25%)
LKYSD : 0.3330 (+17.54%)
PEMTF : 0.1900 (-7.77%)
MOTA.CN : 0.260 (-8.77%)
ABBV : 97.86 (+1.06%)
MMEDF : 0.3350 (+1.55%)
Easing Regulations Place Psychedelic Medical Products on the Path to Growth

, /PRNewswire/ -- In just a few years, the perception about psychedelics and their possible uses has started to shift from a potentially dangerous party drug to an approachable medicinal product. For...

XXII : 0.7542 (-0.21%)
NUMI.VN : 0.300 (-6.25%)
LKYSD : 0.3330 (+17.54%)
CRON : 6.27 (-0.79%)
GTBIF : 11.3165 (+0.23%)
CWBHF : 3.5500 (-6.95%)
Psychedelic-derived Therapies are Just What the Doctor Ordered to Address a Historic Mental Illness Epidemic

, /PRNewswire/ -- While the global death toll caused by the pandemic is well-publicized, a lesser-known side effect of the ongoing pandemic is the rise in mental illness that it has generated. Due to...

SEEL : 1.0000 (-0.99%)
SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.5100 (-1.92%)
NUMI.VN : 0.300 (-6.25%)
LKYSD : 0.3330 (+17.54%)
JNJ : 145.21 (+1.99%)
MMEDF : 0.3350 (+1.55%)
Studies Into Psychedelic Drugs Reveal Significant Medical Potential

, /PRNewswire/ -- Psychedelic drugs include a range of substances with varying pharmacological profiles that all have strong effects on the consumer's conscious experience. Such products are borne from...

AMRS : 4.21 (-4.97%)
VFF : 5.00 (-1.96%)
ZYNE : 3.45 (-7.51%)
NUMI.VN : 0.300 (-6.25%)
LKYSD : 0.3330 (+17.54%)
VFF.TO : 6.78 (-1.88%)
NEPT.TO : 3.97 (-6.81%)
Psychedelic Drugs Could Potentially Treat Impending Post-lockdown Mental Health Epidemic

, /PRNewswire/ --  Trials are already underway testing the use of psychedelics such as psilocybin, LSD, ketamine, ecstasy and other currently scheduled drugs to predicted to hit after the lockdown...

JNJ : 145.21 (+1.99%)
SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.5100 (-1.92%)
LLY : 162.08 (unch)
NUMI.VN : 0.300 (-6.25%)
LKYSD : 0.3330 (+17.54%)
MMEDF : 0.3350 (+1.55%)
BGHM : 0.4600 (+12.20%)
Momentum Builds Behind the Push for Psilocybin Decriminalization

, /PRNewswire/ -- Several recent developments indicate that psychedelic products for medical use are getting the attention of businesses and politicians alike. For example, earlier in April, a lawmaker...

ACB.TO : 16.45 (+0.73%)
CRON : 6.27 (-0.79%)
TLRY : 7.47 (-6.74%)
CGC : 17.30 (-0.69%)
ACB : 12.08 (+0.50%)
NUMI.VN : 0.300 (-6.25%)
LKYSD : 0.3330 (+17.54%)
WEED.TO : 23.64 (-0.08%)
Psychedelics Begin Gradual Climb to Medical Status

, /PRNewswire/ -- The fast pace of technological development in the biotechnology industry and the shifting market demands require continuous innovation. This, in turn, puts pressure on companies to invest...

NUMI.VN : 0.300 (-6.25%)
LKYSD : 0.3330 (+17.54%)
MMEDF : 0.3350 (+1.55%)
SHRMF : 0.5100 (-1.92%)
SHRM.CN : 0.890 (+3.49%)
Trade LKYSD with:

Key Turning Points

2nd Resistance Point 0.3813
1st Resistance Point 0.3572
Last Price 0.3330
1st Support Level 0.2907
2nd Support Level 0.2483

See More

52-Week High 0.9100
Fibonacci 61.8% 0.6655
Fibonacci 50% 0.5900
Fibonacci 38.2% 0.5145
Last Price 0.3330
52-Week Low 0.2700

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar